# A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)

> **NCT00767793** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 84 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Placebo
- **DRUG:** INS117548
- **DRUG:** INS117548
- **DRUG:** INS117548

## Key facts

- **NCT ID:** NCT00767793
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2015-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767793, "A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00767793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*